A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells
Abstract Cisplatin (ddp), which is commonly employed in the treatment of many advanced cancers, often results in initial therapeutic success; however, rapid progression of ddp-resistant cells remains the main reason for treatment failure. Facd with such a problem, we investigated the fitness differe...
Main Authors: | Guihua Duan, Qianyuan Tang, Hongli Yan, Lijuan Xie, Yun Wang, Xi Emily Zheng, Yuzheng Zhuge, Shanshan Shen, Bin Zhang, Xiaoqi Zhang, Jun Wang, Wei Wang, Xiaoping Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-00422-2 |
Similar Items
-
Increased Autophagy Levels Mediate Cisplatin Resistance in Cisplatin-Resistant Cells While Also Rendering Them Vulnerable to Autophagy Induction
by: Guihua Duan, et al.
Published: (2018-01-01) -
Formation of atypical cisplatin-DNA adducts in certain cancer cells
by: Azim-Arahi, Ali
Published: (2003) -
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
by: Zuxiong Tang, et al.
Published: (2021-04-01) -
A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer
by: Haiyong WANG, et al.
Published: (2008-02-01) -
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
by: Xin Gong, et al.
Published: (2017-01-01)